CLINICAL_TRIALS
trial_result
· 2014-07-28
Clinical Trial Update: Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism [Phase 2]
Summary
Phase 2 clinical trial results show normalization of morning testosterone levels in men with secondary hypogonadism.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Repros Therapeutics Inc. | Conditions: Secondary Hypogonadism | Phase 2 | Status: COMPLETED | Results posted: 2014-07-28